home / stock / oncs / oncs news

ONCS News and Press, OncoSec Medical Incorporated From 04/20/20

Stock Information
Company Name: OncoSec Medical Incorporated
Stock Symbol: ONCS
Market: NASDAQ
Menu
ONCS ONCS Quote ONCS Short ONCS News ONCS Articles ONCS Message Board
Get ONCS Alerts

News, Short Squeeze, Breakout and More Instantly...
ONCS - OncoSec Appoints Renowned Oncologist and Immunologist, Herbert Kim Lyerly, M.D., Duke University, to its Board of Directors

SAN DIEGO and PENNINGTON, N.J. , April 20, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (Nasdaq:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the appointment of Herbert Kim Lyerly , M.D., George Barth ...
ONCS - CIM, EURN among premarke losers

OncoSec Medical (NASDAQ: ONCS ) -13% . More news on: OncoSec Medical Incorporated, Chimera Investment Corporation, Co-Diagnostics, Inc., Stocks on the move, , Read more ...

ONCS - W, IMMU, LK and BPT among midday movers

Gainers:  Immunomedics (NASDAQ: IMMU )  +90% . More news on: Immunomedics, Inc., Akers Biosciences, Inc., Exantas Capital Corp., Stocks on the move, , Read more ...

ONCS - Healthcare firms pile on initiatives as COVID-19 pandemic advances

Pfizer ( PFE +1.9% ) and The Pfizer Foundation commit to donate $40M in medical and charitable grants to help fight the pandemic in the U.S. and around the world. More news on: Pfizer Inc., CVS Health Corporation, OPKO Health, Inc., Healthcare stocks news, Stocks on the move, Read ...
ONCS - OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO(TM)

SAN DIEGO and PENNINGTON, N.J. , April 6, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA‑based cancer immunotherapies, today announced that Providence Cancer Institute, a part of ...

ONCS - IMMU, TOT among premarket losers

Cellect Biotechnology (NASDAQ: APOP )  -12%  after recruitment of patients halted and delay in clinical trails due to COVID-19. More news on: Cellect Biotechnology Ltd., Immunomedics, Inc., Frontline Ltd., Stocks on the move, , Read more ...

ONCS - OncoSec Medical Incorporated to Present at the New York City based Investor Summit on March 25th-26th

NEW YORK, NY / ACCESSWIRE / March 20, 2020 / OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer of OncoSec, will present a company overview a...
ONCS - OncoSec Announces Publication of Positive TAVO(TM) Monotherapy Results in Metastatic Melanoma Patients in Annals of Oncology

SAN DIEGO and PENNINGTON, N.J. , March 17, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of positive TAVO™ monotherapy data in...

ONCS - OncoSec Receives $850,000 from The Australian Research and Development (R&D) Tax Incentive Program for TAVO(TM) R&D Work in 2019

SAN DIEGO and PENNINGTON, N.J. , March 11, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that it has received a Research and Development (R&D) Tax Inc...

ONCS - OncoSec Announces Closing of the CGP/Sirtex Transaction

  Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announce...
Previous 10 Next 10